Focal Segmental Glomerulosclerosis: Clinical Trials

1 trial for Focal Segmental Glomerulosclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1

Follow Focal Segmental Glomerulosclerosis: new trials by email Literature Review of Focal Segmental Glomerulosclerosis trials Research Report on Focal Segmental Glomerulosclerosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant
Rituximab, Plasmapheresis - Focal Segmental Glomerulosclerosis
Early Phase 1CompletedUniversity of Minnesota212019-07-012025-09-10

Narrower conditions

Glomerulosclerosis, Focal Segmental (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glomerulonephritis (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Nephritis (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Plasmapheresis (1)  ·  Rituximab (1)

Sponsors

University of Minnesota (1)

Countries

United States (1)

Top investigators

Michelle Rheault, MD (1)

Results publications

PMID 37675355